Eletriptan for the Treatment of Migraine in Patients With Previous Poor Response or Tolerance to Oral Sumatriptan

NCT01989936 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

446

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine With or Without Aura

Interventions

DRUG: Placebo
DRUG: Eletriptan 40 mg
DRUG: Eletriptan 80 mg

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.